Target Patient Population:Patients with antineutrophilcytoplasmic autoantibody (ANCA)-associated vasculitis
Study Overview: To Evaluate the long- term safety and efficacy of Avacopan in patients with Antineutrophil Cytoplasmic Antibody (ANCA)-associated Vasculitis
Study Timeline: Anticipated patient participation is 5 years, 27 visits to the clinic
Number of Patients Currently Active in the Trial: 0
